KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
8.36
+0.27 (3.34%)
At close: Dec 20, 2024, 4:00 PM
8.50
+0.14 (1.67%)
After-hours: Dec 20, 2024, 7:57 PM EST
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $413.13 million as of December 20, 2024. Its market cap has increased by 33.27% in one year.
Market Cap
413.13M
Enterprise Value
283.57M
1-Year Change
33.27%
Ranking
Category
Stock Price
$8.36
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $413.13M, an increase of 219.52%. That is a compound annual growth rate of 12.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 413.10M | -2.41% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korro Bio | 403.96M |
| Community Health Systems | 402.48M |
| Arcturus Therapeutics Holdings | 401.98M |
| National Research | 400.74M |
| Monte Rosa Therapeutics | 399.95M |
| Akebia Therapeutics | 390.54M |
| Enhabit | 387.19M |
| Alpha Teknova | 385.95M |